مكتبة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Efficacy and Safety of Combination Therapy With Immune Checkpoint Inhibitors and Chemotherapy With Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer: A Systematic Review.

Authors : Sohrabi H; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.; Ghavam SM

Subjects: Paclitaxel*/Paclitaxel*/Paclitaxel*/administration & dosage ; Paclitaxel*/Paclitaxel*/Paclitaxel*/adverse effects ; Paclitaxel*/Paclitaxel*/Paclitaxel*/therapeutic use

Source: Cancer medicine [Cancer Med] 2026 Feb; Vol. 15 (2), pp. e71637.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Sintilimab plus cisplatin and nab-paclitaxel induction treatment for locally advanced borderline-resectable oesophageal squamous cell carcinoma: A single-arm, prospective, phase 2 study (NEOCRTEC2001).

Authors : Wu JD; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.; Wang DS

Subjects: Paclitaxel*/Paclitaxel*/Paclitaxel*/therapeutic use ; Paclitaxel*/Paclitaxel*/Paclitaxel*/pharmacology ; Paclitaxel*/Paclitaxel*/Paclitaxel*/administration & dosage

Source: Clinical and translational medicine [Clin Transl Med] 2026 May; Vol. 16 (5), pp. e70691.Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet ISSN: 2001-1326

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Retrospective analysis of the clinical efficacy of neoadjuvant chemotherapy albumin paclitaxel combined with carboplatin in the treatment of triple-negative breast cancer.

Authors : Zhang H; Department of thyroid and breast surgery, The affiliated People's Hospital of Shandong First Medical University, Jinan, China.; Sun Y

Subjects: Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/pathology ; Carboplatin*/Carboplatin*/Carboplatin*/administration & dosage

Source: Scientific reports [Sci Rep] 2025 Dec 05; Vol. 15 (1), pp. 43356. Date of Electronic Publication: 2025 Dec 05.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The Sigma-1 Gene as a Prognostic Marker in Chemotherapy-Treated Breast Cancer-Antagonists' Synergism With Paclitaxel In Vitro.

Authors : Borde P; Royal College of Surgeons in Ireland, Medical University of Bahrain, Busaiteen, Bahrain.; Abdulla A

Subjects: Receptors, sigma*/Receptors, sigma*/Receptors, sigma*/genetics ; Receptors, sigma*/Receptors, sigma*/Receptors, sigma*/antagonists & inhibitors ; Receptors, sigma*/Receptors, sigma*/Receptors, sigma*/metabolism

Source: Cancer medicine [Cancer Med] 2025 Nov; Vol. 14 (21), pp. e71376.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The PD-1 and CD28 molecules on T cells in peripheral blood are associated with the prognosis of patients with advanced breast cancer receiving paclitaxel chemotherapy.

Authors : Yang J; Basic Medicine Laboratory, General Hospital of Northern Theater Command, Shenyang, China.; Qu S

Subjects: Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/metabolism ; Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/blood ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy

Source: PloS one [PLoS One] 2026 Apr 06; Vol. 21 (4), pp. e0344366. Date of Electronic Publication: 2026 Apr 06 (Print Publication: 2026).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Post hoc subgroup analysis of neoadjuvant gemcitabine plus S1 vs gemcitabine plus nab paclitaxel in elderly resectable/borderline resectable pancreatic adenocarcinoma.

Authors : Yamada D; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Yamadaoka 2-2, Suita, Osaka, 565-0871, Japan.; Kobayashi S

Subjects: Albumins*/Albumins*/Albumins*/administration & dosage ; Albumins*/Albumins*/Albumins*/therapeutic use ; Albumins*/Albumins*/Albumins*/adverse effects

Source: Scientific reports [Sci Rep] 2025 Nov 12; Vol. 15 (1), pp. 39597. Date of Electronic Publication: 2025 Nov 12.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Effect of Immersive Virtual Reality on Chemotherapy-Related Side Effects in Patients Receiving Paclitaxel-Carboplatin With or Without Bevacizumab: 2-Arm Randomized Controlled Trial.

Authors : Niki K; Department of Clinical Pharmacy Research and Education, The University of Osaka Graduate School of Pharmaceutical Sciences, Yamadaoka 1-6, Osaka, Suita, 565-0871, Japan, 81 6-6879-8250.; Nakagawa S

Subjects: Bevacizumab*/Bevacizumab*/Bevacizumab*/adverse effects ; Bevacizumab*/Bevacizumab*/Bevacizumab*/administration & dosage ; Bevacizumab*/Bevacizumab*/Bevacizumab*/therapeutic use

Source: Journal of medical Internet research [J Med Internet Res] 2025 Aug 14; Vol. 27, pp. e65924. Date of Electronic Publication: 2025 Aug 14.Publisher: JMIR Publications Country of Publication: Canada NLM ID: 100959882 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The Efficacy and Safety of Nab-Paclitaxel Plus Anlotinib in Small-Cell Lung Cancer for Second-Line Therapy.

Authors : Tian LJ; Department of Oncology, Shandong University Cancer Center, Jinan, Shandong, China.; Department of Oncology, Binzhou Medical University Hospital, Binzhou, Shandong, China.

Subjects: Paclitaxel*/Paclitaxel*/Paclitaxel*/administration & dosage ; Paclitaxel*/Paclitaxel*/Paclitaxel*/therapeutic use ; Paclitaxel*/Paclitaxel*/Paclitaxel*/pharmacology

Source: Thoracic cancer [Thorac Cancer] 2026 May; Vol. 17 (9), pp. e70290.Publisher: Wiley Publishing Asia Pty Ltd Country of Publication: Singapore NLM ID: 101531441 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Intensive treatment of triple negative breast cancer with residual positive axillary lymph node after neoadjuvant chemotherapy.

Authors : Wang X; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Cancer Prevention and Treatment Center, Peking University Cancer Hospital & Institute, Beijing, 100142, China.; He Y

Subjects: Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/pathology ; Neoadjuvant Therapy*/Neoadjuvant Therapy*/Neoadjuvant Therapy*/methods

Source: BMC women's health [BMC Womens Health] 2024 Nov 27; Vol. 24 (1), pp. 629. Date of Electronic Publication: 2024 Nov 27.Publisher: BioMed Central Country of Publication: England NLM ID: 101088690 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6874

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The impact of Paclitaxel-based hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer patients - interim analysis of safety and immediate efficacy of a randomized control trial (C-HOC trial).

Authors : Wang Q; Department of Gynecology and Obstetrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; Liu H

Subjects: Paclitaxel*/Paclitaxel*/Paclitaxel*/administration & dosage ; Paclitaxel*/Paclitaxel*/Paclitaxel*/therapeutic use ; Hyperthermic Intraperitoneal Chemotherapy*/Hyperthermic Intraperitoneal Chemotherapy*/Hyperthermic Intraperitoneal Chemotherapy*/methods

Source: Journal of ovarian research [J Ovarian Res] 2024 Jul 12; Vol. 17 (1), pp. 145. Date of Electronic Publication: 2024 Jul 12.Publisher: BioMed Central Country of Publication: England NLM ID: 101474849 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-2215

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Efficacy and Safety of Combination Therapy With Immune Checkpoint Inhibitors and Chemotherapy With Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer: A Systematic Review.

Sintilimab plus cisplatin and nab-paclitaxel induction treatment for locally advanced borderline-resectable oesophageal squamous cell carcinoma: A single-arm, prospective, phase 2 study (NEOCRTEC2001).

Retrospective analysis of the clinical efficacy of neoadjuvant chemotherapy albumin paclitaxel combined with carboplatin in the treatment of triple-negative breast cancer.

The Sigma-1 Gene as a Prognostic Marker in Chemotherapy-Treated Breast Cancer-Antagonists' Synergism With Paclitaxel In Vitro.

The PD-1 and CD28 molecules on T cells in peripheral blood are associated with the prognosis of patients with advanced breast cancer receiving paclitaxel chemotherapy.

Post hoc subgroup analysis of neoadjuvant gemcitabine plus S1 vs gemcitabine plus nab paclitaxel in elderly resectable/borderline resectable pancreatic adenocarcinoma.

Effect of Immersive Virtual Reality on Chemotherapy-Related Side Effects in Patients Receiving Paclitaxel-Carboplatin With or Without Bevacizumab: 2-Arm Randomized Controlled Trial.

The Efficacy and Safety of Nab-Paclitaxel Plus Anlotinib in Small-Cell Lung Cancer for Second-Line Therapy.

Intensive treatment of triple negative breast cancer with residual positive axillary lymph node after neoadjuvant chemotherapy.

The impact of Paclitaxel-based hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer patients - interim analysis of safety and immediate efficacy of a randomized control trial (C-HOC trial).

اتصل بنا

اتبع